English
Take Solutions Q3 Results
- BSE: 532890
- NSE: TAKE
- ISIN: INE142I01023
- Sector: Biotechnology & Drugs
BSE
42.85
-1.10 (-2.50%)
-1.10 (-2.50%)Volume1.62 L
Updated: Wed 14 Jan, 2026 | 15:20:51
NSE
43.00-0.73 (-1.67%)
-0.73 (-1.67%)Volume1.30 M
Updated: Wed 14 Jan, 2026 | 15:29:32
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - Take Solutions Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 2.90 | -0.58 | 0.00% | 2.08 | 39.32% |
| Depreciation/ Amortization | 0.01 | 0.01 | 0.00% | 0.11 | -89.62% |
| Operating Income | -2.90 | 0.58 | 0.00% | -2.08 | 39.32% |
| Net Income | 47.68 | -1.58 | 0.00% | -2.14 | 0.00% |
| Other Operating Expenses Total | 2.48 | -0.83 | 0.00% | 1.50 | 65.18% |
| Net Income Before Taxes | 4.90 | 0.08 | 6426.67% | -1.89 | 0.00% |
| Total Revenue | 0.00 | 0.00 | 0.00% | 0.00 | 0.00% |
| Selling/ General/ Admin Expenses Total | 0.41 | 0.24 | 73.00% | 0.48 | -13.68% |
| Diluted Normalized EPS | 0.33 | 0.01 | 3751.55% | -0.38 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.